📢 #SEQT_articles "Computational drug repurposing approaches identify fingolimod as potential antiviral against COVID-19" 🔗 https://t.co/aORZxLqCBj Institutions: @CIB_CSIC @i2sysbio Authors: Javier García Marín, Ron Geller #COVID19 #SARSCoV2 #VirtualScreening #DrugRepurposing

Institutions: @USPCEU @cibir_rioja @UniCologne Authors: Irene Ortín Remón, Ana Ramos, Beatriz de Pascual-Teresa, Alfredo Martínez Ramírez, Laura Ochoa

📢 #SEQT_articles "Targeting Protein Kinase 2 and Histone Deacetylase with a Dual Inhibitor Effectively Reduces Tumor Growth in a Triple-Negative Breast Cancer Xenograft Model” 🔗 https://t.co/RCMwbm2l2F #DrugDiscovery #CancerResearch #multitarget #approach #PROLIGAR

🚨MEDCHEMTRAINING! A new series of webinars organised by the ECS group of the @SocEspQuimTerap, focused on developing soft skills for the medchem community. 📅 October 30th, 12:30 PM By Fernando Gomollón, Co-founder of Agata Communications. 🔗 https://t.co/UVvEzJzE5p

🧪 ¡Buscamos al Comité Organizador del Simposio de Jóvenes SEQT 2026 de Valencia! 📅 Deadline: 15/10 ✉️ Mail to seqt.ecs@seqt.org con tu carta de motivación + CV. 👉 Regístrate como soci@ de la SEQT y miembr@ de ECS 🔗 https://t.co/rMtEF6hmAL

Speakers: • Dr. Ricardo A. M. Serafim - @IQSbarcelona • Marta Durán Martínez - @UAHes • Elena Caballero Sánchez - @CIB_CSIC 👉 Register here to secure your place:

⏳We are excited to invite you to the first edition of #MEDCHEMXCHANGE, a new webinar series launched by SEQT-ECS in collaboration with the @EFMC @YoungSciNet as part of their #LunchandLearn initiative. 📌Protein Kinases as Drug Targets 📅Thursday, 11 September – 13:00 CET

📢#SEQT_articles "Highly potent dipeptidyl peptidase 8/9 (DPP8/9) inhibitors designed via relative binding free energy calculations" 👉If you want to know more: https://t.co/6z1UyM1TRv Authors: @VanesaNozal @UAntwerpen @IQSbarcelona #ComputationalChem #MedChem #peptidase #hERG

OC2: Oscar Díaz from CINN-CSIC with a talk “DESIGN AND RATIONALE OF PYRIMIDINONE DERIVATIVES AS DUAL A2A/A2B ADENOSINE RECEPTOR ANTAGONISTS: A NOVEL FAMILY OF IMMUNO-ONCOLOGY THERAPY CANDIDATES” #SEQT_YRS2025

OC1: Anna Sampietro from MCP group with a talk entitled “Targeting Keap1 E3 ligase: PROTACs with dual mechanism of action” #SEQT_YRS2025

First plenary lecture of the YRS by Laia Josa-Culleré from IQAC-CSIC #SEQT_YRS2025

Now, Noemí Martínez, representing the organizing committee in the inauguration talk #SEQT_YRS2025

YRS inauguration by the president of the @SocEspQuimTerap José Manuel Bartolomé #SEQT_YRS2025

The registration for the XI Young Researchers Symposium has started! 📣🤩 Follow us 👉🏻 #SEQT_YRS2025

@g_sbardella @UniSalerno @GalChimia Last workshop of the Summer School about intellectual property and patent system by Iain McGeoh and Susana Egusquiaguirre from Abg Intellectual Property

@g_sbardella @UniSalerno @GalChimia Ana Palma from FAES FARMA in the talk focused on clínicas development and case study

@g_sbardella @UniSalerno @GalChimia Mridvika Narda from Almirall with her talk focused on Regulatory toxicology and pharmacology

@g_sbardella @UniSalerno @GalChimia José Luis Velada from FAES FARMA with a talk entitled: Drug Delivery: Formulation Optimizagion and Bioavailability

@g_sbardella @UniSalerno Last day of the IX Summer School starts with Jacobo Cruces from @GalChimia with a talk entitled Drug development and scale up

@g_sbardella @UniSalerno SEQT Summer School awards: Best Flash Presentation: Tuo Chen Best poster: Luisa Camerin